How will the reporting recommendations for tumor marker prognostic studies affect clinical trials?

2013 ◽  
Vol 3 (4) ◽  
pp. 315-317
Author(s):  
Sheila E Taube ◽  
Daniel F Hayes
Keyword(s):  
Clinical Trials ◽  
Tumor Marker ◽  
Reporting Recommendations

REporting recommendations for tumor MARKer prognostic studies (REMARK)

2006 ◽  
Vol 100 (2) ◽  
pp. 229-235 ◽  
Author(s):  
Lisa M. McShane ◽  
Douglas G. Altman ◽  
Willi Sauerbrei ◽  
Sheila E. Taube ◽  
Massimo Gion ◽  
...  
Keyword(s):  
Tumor Marker ◽  
Reporting Recommendations

Adherence to CONSORT harms-reporting recommendations in publications of recent analgesic clinical trials: An ACTTION systematic review

Pain ◽  
2012 ◽  
Vol 153 (12) ◽  
pp. 2415-2421 ◽  
Author(s):  
Shannon M. Smith ◽  
Daniel R. Chang ◽  
Anthony Pereira ◽  
Nirupa Shah ◽  
Ian Gilron ◽  
...  
Keyword(s):  
Systematic Review ◽  
Clinical Trials ◽  
Reporting Recommendations

scholarly journals RESPONSE: Re: Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK)

2005 ◽  
Vol 97 (24) ◽  
pp. 1855-1856 ◽  
Author(s):  
Lisa M. McShane ◽  
Douglas G. Altman ◽  
Willi Sauerbrei ◽  
Sheila E. Taube ◽  
Massimo Gion ◽  
...  
Keyword(s):  
Tumor Marker ◽  
Reporting Recommendations

scholarly journals Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): Explanation and Elaboration

PLoS Medicine ◽  
2012 ◽  
Vol 9 (5) ◽  
pp. e1001216 ◽  
Author(s):  
Douglas G. Altman ◽  
Lisa M. McShane ◽  
Willi Sauerbrei ◽  
Sheila E. Taube
Keyword(s):  
Tumor Marker ◽  
Reporting Recommendations

Biomarkers for Prognosis in Pancreatic Neuroendocrine Tumors

2021 ◽  
Author(s):  
Mojun Zhu ◽  
Karl R. Sorenson ◽  
Rebecca Liu ◽  
Bonnie E. Gould Rothberg ◽  
Thorvardur R Halfdanarson
Keyword(s):  
Systematic Review ◽  
Tumor Marker ◽  
Clinical Outcomes ◽  
Neuroendocrine Tumors ◽  
Diverse Group ◽  
Pancreatic Neuroendocrine Tumors ◽  
Inclusion Criteria ◽  
Pubmed Database ◽  
Histological Heterogeneity ◽  
Reporting Recommendations

Pancreatic neuroendocrine tumors (PNETs) encompass a diverse group of malignancies marked by histological heterogeneity and highly variable clinical outcomes. We performed a systematic review on potential prognostic biomarkers in PNETs by searching the PubMed database. A total of 472 manuscripts were reviewed in detail and 52 multivariate studies met the inclusion criteria proposed by the Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK). These altogether analyzed 53 unique targets and 36 of them were statistically associated with survival.

REMARK (REporting Recommendations for Tumor MARKer Prognostic Studies)

2014 ◽  
pp. 241-249 ◽  
Author(s):  
Douglas G. Altman ◽  
Lisa M. McShane ◽  
Willi Sauerbrei ◽  
Sheila E. Taube ◽  
Margaret M. Cavenagh
Keyword(s):  
Tumor Marker ◽  
Reporting Recommendations

scholarly journals Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): An Abridged Explanation and Elaboration

2018 ◽  
Vol 110 (8) ◽  
pp. 803-811 ◽  
Author(s):  
Willi Sauerbrei ◽  
Sheila E Taube ◽  
Lisa M McShane ◽  
Margaret M Cavenagh ◽  
Douglas G Altman
Keyword(s):  
Tumor Marker ◽  
Reporting Recommendations
Sign in / Sign up

Export Citation Format

Share Document